Bergstresser P R
Department of Dermatology, University of Texas Southwestern Medical Center, Dallas.
Arch Dermatol. 1989 Feb;125(2):276-9. doi: 10.1001/archderm.125.2.276.
The problem of contact allergic dermatitis in humans and contact hypersensitivity in laboratory animals begins with the observation that certain reactive compounds, when placed on skin, lead to a reproducible and characteristic inflammatory reaction. The immunologic processes that conspire to produce this damaging tissue reaction are derived from the normal immunologic balance between a protection of self and a destruction of nonself. Experimental work in the last decade has focused on the role of antigen-presenting cells, and specifically Langerhans' cells, in its initiation, as well as on the competing roles of subsets of T lymphocytes in its regulation. For humans, an important goal has been the development of techniques by which tolerization and desensitization may be achieved, and for those who work with laboratory animals, contact hypersensitivity has provided methods to examine immunoregulation in general. In the coming decade, new techniques from molecular biology, molecular genetics, tissue culture, and, above all, shrewd clinical observation will provide a new array of ideas and possibilities.
某些反应性化合物涂于皮肤上时,会引发可重现的特征性炎症反应。导致这种组织损伤反应的免疫过程源自自身保护与非自身破坏之间正常的免疫平衡。过去十年的实验工作聚焦于抗原呈递细胞,特别是朗格汉斯细胞在其起始过程中的作用,以及T淋巴细胞亚群在其调节中的竞争作用。对人类而言,一个重要目标是开发实现免疫耐受和脱敏的技术,而对于从事实验动物研究的人员来说,接触性超敏反应为总体研究免疫调节提供了方法。在未来十年,来自分子生物学、分子遗传学、组织培养的新技术,尤其是敏锐的临床观察,将带来一系列新的思路和可能性。